News
Ny rapport: Helsenæringens verdi 2019
Rapporten gir innsikt i en næring som i 2018 omsatte for 142 milliarder kroner.
Meet our new members
Oslo Cancer Cluster proudly presents the new members who have joined our organisation during the first quarter of 2019.
The first Norwegian CAR
Made in Oslo, the first ever Norwegian CAR T cell is now a fact.
Encouraging news from BerGenBio
A second group of patients have been added to an ongoing phase II clinical study of a drug combination to treat lung cancer.
Giving patients a stronger voice
How can the voices of cancer patients be heard when evaluating new methods of treatment?
Chemistry with mutual benefits
Students were taught about the chemistry behind developing cancer treatments in the Oslo Cancer Cluster Incubator.
Transporting patients
Student Jørgen Amdim got to experience life as an orderly at the Radium Hospital.
Natural killer cells dressed to kill cancer cells
A new study may potentially enable scientists to provide cancer immunotherapy that is cheaper, faster and more manageable.
The Incubator Labs are expanding
The laboratories at Oslo Cancer Cluster Incubator are expanding to meet increasing demand from members.
Attracting clinical trials to Norway
Dr. Jon Amund Kyte at Oslo University Hospital aims to bring more and better clinical trials to Norway.
Promising start for expansion group of Targovax clinical trial
Targovax, one of the members of Oslo Cancer Cluster, has begun an expansion patient group in the clinical trial of a drug to treat skin cancer. The company Targovax is developing immune activators to target solid tumours that are difficult to treat. The drug in question, called ONCOS-102, is aimed at patients with malignant melanoma (skin […]
New collaboration aims to treat cervical cancer
Vaccibody and Roche have started a new collaboration to investigate a drug combination for patients with advanced cervical cancer.
